Scarica l'app Stockscreener
35.41
1.44%
-0.575
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$35.99
Aprire:
$36.23
Volume 24 ore:
802.24K
Relative Volume:
0.39
Capitalizzazione di mercato:
$5.62B
Reddito:
$264.79M
Utile/perdita netta:
$-14.36M
Rapporto P/E:
-321.95
EPS:
-0.11
Flusso di cassa netto:
$-28.11M
1 W Prestazione:
-5.08%
1M Prestazione:
-3.40%
6M Prestazione:
+6.29%
1 anno Prestazione:
+79.05%
Intervallo 1D:
$35.39
$36.50
Intervallo di 1 settimana:
$35.52
$37.93
Portata 52W:
$16.65
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
Nome
Tg Therapeutics Inc
Settore
Industria
Telefono
(212) 554-4484
Indirizzo
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Confronta TGTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
35.42 | 5.86B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.00 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.58 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.20 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
597.70 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
306.34 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2024-10-29 | Iniziato | TD Cowen | Buy |
| 2023-08-02 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-26 | Ripresa | Jefferies | Buy |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2021-11-15 | Downgrade | Goldman | Neutral → Sell |
| 2021-04-20 | Iniziato | Goldman | Neutral |
| 2021-04-19 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-01 | Iniziato | JP Morgan | Overweight |
| 2020-08-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Iniziato | Evercore ISI | Outperform |
| 2020-01-17 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-02-06 | Ripresa | Jefferies | Buy |
| 2018-09-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Ripresa | H.C. Wainwright | Buy |
| 2017-04-25 | Iniziato | Jefferies | Buy |
| 2017-03-06 | Reiterato | FBR & Co. | Outperform |
| 2016-10-06 | Ripresa | Brean Capital | Buy |
| 2016-05-27 | Iniziato | SunTrust | Buy |
| 2015-12-01 | Iniziato | FBR Capital | Outperform |
| 2015-09-09 | Iniziato | Raymond James | Strong Buy |
| 2015-08-12 | Ripresa | H.C. Wainwright | Buy |
| 2015-06-19 | Reiterato | Brean Capital | Buy |
| 2014-12-11 | Reiterato | ROTH Capital | Buy |
| 2014-12-10 | Reiterato | ROTH Capital | Buy |
Mostra tutto
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q2 Release - Yahoo Finance
What are analysts’ price targets for TG Therapeutics Inc. in the next 12 monthsBest Dividend Updates From AI Tools - jammulinksnews.com
What institutional investors are buying TG Therapeutics Inc. stockCapitalize on proven trading setups - jammulinksnews.com
How strong is TG Therapeutics Inc. company’s balance sheetAccelerate your capital gains today - jammulinksnews.com
How does TG Therapeutics Inc. compare to its industry peersDiscover high-growth stocks for your portfolio - jammulinksnews.com
What catalysts could drive TG Therapeutics Inc. stock higher in 2025Exceptional portfolio growth - jammulinksnews.com
Does TG Therapeutics Inc. stock perform well during market downturnsUnlock expert insights for smarter investing - jammulinksnews.com
Jim Cramer on TG Therapeutics: “You Should Buy the Stock” - MSN
Will TG Therapeutics Inc. stock benefit from interest rate changesSkyrocketing profit margins - jammulinksnews.com
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), TG Therapeutics (TGTX) and Ardelyx (ARDX) - The Globe and Mail
TG Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and TG Therapeutics (TGTX) - The Globe and Mail
Is TG Therapeutics Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional
What analysts say about TG Therapeutics Inc. stockRapid wealth multiplication - jammulinksnews.com
What drives TG Therapeutics Inc. stock priceUnstoppable trading performance - Autocar Professional
How To Trade (TGTX) - news.stocktradersdaily.com
TG Therapeutics Joins Rank Of Stocks With RS Ratings Over 90 - MSN
A Note On TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE and Debt To Equity - simplywall.st
Goldman Sachs resumes TG Therapeutics stock coverage with Neutral rating By Investing.com - Investing.com Canada
We Think TG Therapeutics (NASDAQ:TGTX) Can Stay On Top Of Its Debt - 富途牛牛
Cramer's Lightning Round: TG Therapeutics is a buy - MSN
SHAREHOLDER COMPLAINT: Levi & Korsinsky LLP Files Case in U.S. District Court to Recover Losses Suffered By Investors in TG Therapeutics, Inc.Sets Lead Plaintiff Deadline of March 7, 2017 - ACCESS Newswire
14 Stocks Jim Cramer Recently Looked At - Insider Monkey
Cramer Backs This Mining Giant After $1.6B Bet - Benzinga
TG Therapeutics: Cramer's Bullish Call Amid Clinical Pipeline Potential - AInvest
TG Therapeutics: Strong Execution Tempered By An Evolving Market (NASDAQ:TGTX) - Seeking Alpha
Long Term Trading Analysis for (TGTX) - news.stocktradersdaily.com
TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel (NASDAQ:TGTX) - Seeking Alpha
Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance
Have Insiders Sold TG Therapeutics Shares Recently? - simplywall.st
Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock - Nasdaq
Tg therapeutics director Yann Echelard sells $369,400 in stock - Investing.com Australia
(TGTX) Trading Advice - news.stocktradersdaily.com
Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
9.07%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):